Issue
Clinical symptoms during the presentation may include abdominal pain, abdominal pain, weight, increased abdominal size, abdominal strength, ASTSITNOY (accumulation of fluid in the abdominal cavity), fever, weight loss, fatigue, anemia and disorders of the digestive system. Some patients complain more nonspecific symptoms for several months before confirmed diagnosis. Percentage of cases, peritoneal mesothelioma is found incidentally when a patient tried to help yet another health problem such as gallbladder, hernia or pelvic mass.
Diagnosis
Like all mesotheliomas, diagnosis of peritoneal mesothelioma may be difficult. CT can help distinguish between two types of clinical peritoneal mesothelioma, described as a "dry" or "wet" as their performances are very different from the image. In the "dry" type, CT may show some small masses, or one dominant localized mass. It is not as a rule, little or no ASTSITNOY. In "wet" type, CT may be a small nodule is widespread, but not the dominant mass. ASTSITNOY usually present.
If the liquid is present, it can be removed in a procedure called paracentesis. Unfortunately, as in the case of pleural mesothelioma, an analysis of fluid offers limited diagnostic value. There are usually biopsy tissue in laproscopic negotiations, the final diagnosis.
On the stage
There is currently no system for the staging of peritoneal mesothelioma, and if the disease is staged, which usually takes place in accordance with the TNM system, the most frequently occurring cancer among the general system. The system is the location of the tumor (T), lymph nodes (N), and metastasis (M). They are not common types can also be quite useful in determining the stage.
The first category shows a defeat in a position to fully resected (removed). In the second category, the disease is in the abdomen and peritoneal surfaces in the body, where debulking (lifting so much, but not all the tumor) is possible. Rating sampling three diseases in the abdominal cavity with the invasion of bodies as the liver or intestines. Category Four shows the expansion of the disease outside the abdominal cavity.
Treatment
In recent years, the combined treatment of peritoneal mesothelioma has become common for people suffering because surgery alone and / or intraperitoneal chemotherapy alone proved no less effective. Cytoreductive (debulking) surgery to remove all or almost all the visible tumor and, depending on choice of doctor, can be combined with intra-peritoneal hyperthermal chemotherapy (IPHC), intraperitoneal chemotherapy and / or radiation. As it is not always possible to remove all the tumor prognosis for long-term survival could depend on the integrity quote, as provided by the following criteria:
The full quote:
CC-0 peritoneal seeding will not be shown in operational activities.
CC-1 knot less than 2.5 cm, even after the course. Units of this size are thought to be overcome by intracavitary chemotherapy, the so-called full quote.
Imcomplete I quote:
CC-2 site from 2.5 to 5 cm, even after the course.
CC-3 knots more than 5 cm or merger unresectable tumor node anywhere inside the abdomen or pelvis.
For patients, the spread of disease, in which the operation was not a "potentially curative", palliation of symptoms can be achieved by debulking. With peritoneal mesothelioma is a rare malignant, special care must be approved by doctors not to illness.